Cart is Empty


DIN: 02425068, 02425076, 02425084, 02425092, 02425106
Health Canada 'Drug Schedule': Prescription

Only original prescriptions can be accepted. No copies.

Type Yellow - 112.5 mg, each pack QTY. PRICE (CAD) $38.08
Type Orange - 250 mg, each pack QTY. PRICE (CAD) $39.39
Type Green - 500 mg, each pack QTY. PRICE (CAD) $40.70
Type Blue - 1000 mg, each pack QTY. PRICE (CAD) $42.00
Type Pink - 1400 mg, each pack QTY. PRICE (CAD) $43.33

BRAVECTO kills fleas and is indicated for the treatment and prevention of flea infestations (Ctenocephalides felis) and for the treatment and control of tick infestations with Dermacentor variabilis (American dog tick) for 12 weeks.

BRAVECTO is also indicated as an aid in the treatment and control of tick infestations with Ixodes scapularis (black-legged tick) and Rhipicephalus sanguineus (brown dog tick) for 12 weeks.

BRAVECTO is indicated for dogs and puppies 6 months of age and older and weighing 2 kg or greater.

BRAVECTO should be administered orally as a single dose every 12 weeks according to the Dosage Schedule below to provide a minimum dose of 25 mg/kg body weight.
BRAVECTO should be administered with food.

Dosage Schedule


Body Weight Ranges (kg) Chewable Tablet weight (g) Fluralaner content (mg) Chewable Tablets Administered Package colour
2 - 4.5 0.82 112.5 One Yellow
> 4.5 - 10 1.83 250 One Orange
> 10 - 20 3.67 500 One Green
> 20 - 40 7.33 1000 One Blue
> 40 - 56* 10.26 1400 One Pink

* Dogs over 56 kg should be administered the appropriate combination of chewable tablets

Treatment with BRAVECTO may begin at any time of the year. Due to climate variations across the country, Canada has highly variable distributions and abundance of flea and tick infestations. A comprehensive plan, based on regional risk assessment is recommended to determine an appropriate dosing interval.

This product should not be given to dogs with known or suspected allergy or intolerance to fluralaner or other components of this product.

BRAVECTO has not been shown to be effective for 12-weeks duration in puppies less than 6 months of age.

Not for human use. Keep out of the reach of children. Keep the product in the original packaging until use, in order to prevent children from getting direct access to the product. Do not eat, drink or smoke while handling the product. Wash hands thoroughly with soap and water immediately after use of the product.

In a well-controlled US field study, which included 294 dogs (224 dogs were administered BRAVECTO every 12 weeks and 70 dogs were administered an oral active control every 4 weeks and were provided with a tick collar); there were no serious adverse reactions. All potential adverse reactions were recorded in dogs treated with BRAVECTO over a 182-day period and in dogs treated with the active control over an 84-day period. The most frequently reported adverse reaction in dogs in the BRAVECTO and active control groups was vomiting.


PetsDrugMart only dispenses Health Canada approved prescription medication; and ships ONLY within Canada as long as a valid Canadian prescription has been provided with an order.